Carregant...
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lun...
Guardat en:
| Publicat a: | Front Immunol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7943455/ https://ncbi.nlm.nih.gov/pubmed/33717193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.640093 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|